Kai Lv
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Organic Chemistry top 5%
- Synthesis and biological activity
- Synthesis and Biological Evaluation
- Quinazolinone synthesis and applications
Papers in
-
- Cancer therapeutics and mechanisms 30
- Phenothiazines and Benzothiazines Synthesis and Activities 13
-
- Tuberculosis Research and Epidemiology 13
- Co-authors
- Mingliang Liu (51 shared papers)Huiyuan Guo (20 shared papers)Yu Lu (22 shared papers)Apeng Wang (28 shared papers)Lian‐Shun Feng (8 shared papers)Yun Chai (9 shared papers)Dong Ma (13 shared papers)Guowei Li (10 shared papers)
- Journals
- European Journal of Medicinal Chemistry (23 papers)Bioorganic & Medicinal Chemistry Letters (5 papers)Bioorganic Chemistry (5 papers)ACS Medicinal Chemistry Letters (4 papers)Bioorganic & Medicinal Chemistry (3 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Kai Lv
83 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 112
- Molecular Medicine 109
- Organic Chemistry 604
- Infectious Diseases 357
- Toxicology 35
- Molecular Biology 701
Countries citing papers authored by Kai Lv
This map shows the geographic impact of Kai Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Lv more than expected).
Fields of papers citing papers by Kai Lv
This network shows the impact of papers produced by Kai Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Lv. The network helps show where Kai Lv may publish in the future.
Co-authors
The 25 scholars most cited alongside Kai Lv, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 88 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 108 | |
| 2 | 2019 | 105 | |
| 3 | 2017 | 54 | |
| 4 | 2012 | 53 | |
| 5 | 2017 | 40 | |
| 6 | 2011 | 39 | |
| 7 | 2018 | 36 | |
| 8 | 2016 | 35 | |
| 9 | 2023 | 34 | |
| 10 | 2017 | 31 | |
| 11 | 2019 | 31 | |
| 12 | 2023 | 30 | |
| 13 | 2011 | 30 | |
| 14 | 2021 | 30 | |
| 15 | 2011 | 29 | |
| 16 | 2022 | 29 | |
| 17 | 2011 | 28 | |
| 18 | 2018 | 28 | |
| 19 | 2018 | 27 | |
| 20 | 2023 | 27 |
About Kai Lv
Kai Lv is a scholar working on Molecular Biology, Infectious Diseases, Organic Chemistry, Epidemiology and Biomedical Engineering, having authored 88 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (30 papers), Phenothiazines and Benzothiazines Synthesis and Activities (13 papers), Tuberculosis Research and Epidemiology (13 papers), Antibiotic Resistance in Bacteria (10 papers), Quinazolinone synthesis and applications (9 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers), Hepatitis B Virus Studies (7 papers) and Nanoplatforms for cancer theranostics (7 papers). The work is most often cited by research in Molecular Medicine (109 citations), Organic Chemistry (604 citations), Infectious Diseases (357 citations), Toxicology (35 citations) and Molecular Biology (701 citations). Kai Lv has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Mingliang Liu, Huiyuan Guo, Yu Lu, Apeng Wang, Lian‐Shun Feng, Yun Chai, Dong Ma, Guowei Li, Bo Wang and Xiaowei Liu. Their work appears in journals such as European Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Bioorganic Chemistry, ACS Medicinal Chemistry Letters and Bioorganic & Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.